Evotec expands alliance with Harvard University

Tuesday 17 January 2012

Evotec AG has announced a second strategic alliance with Harvard University, this time to discover and develop biomarkers and treatments for kidney disease. This follows an earlier deal to develop diabetes therapies targeting beta cell regeneration.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany